KINFO: Kasvigenetiikan luennot ja harjoitukset ja Biotechnology in Health and Disease 26.-28.3.2012

[Milla Kumin]

Seuraavat kurssit:

Kasvigenetiikan luennot KABI3022
ja
Kasvigenetiikan harjoitukset (KABI3023)
 
muuttuvat vuodesta 2012 alkaen parillisina vuosina pidettäviksi. Lisätietoja: esatyy at utu.fi.
 
Terveisin Esa Tyystjärvi

---------------------------------------------------------------------------------

Hei,

26.-28.3.2012 järjestetään Turun yliopiston biotekniikan osaston ja kansallisen DIA-NET tohtoriohjelman järjestämä kurssi "Biotechnology in  Health and Disease".

Kurssi on englanninkielinen.

---

On 26.-28.3.2012 the University of Turku Department of Biotechnology and the National DIA-NET Doctoral Programme are organizing a three-day course "Biotechnology in  Health and Disease".

---

Mon 26.03. at 10:00 - 16:00, Dentalia-building, Arje-Scheinin -auditorium, Lemminkäisenkatu 2, 2nd floor
Tue 27.03. at 8:00 - 14:00, Medisiina-building, Exterum-auditorium, Kiinanmyllynkatu 10, 1st floor
Wed 28.03 at 8:00 - 16:00, Mikro-building, auditorium, Kiinamyllynkatu 13, 1st floor

Title: Diagnostic technologies  -  reporters, platforms and reagents

Target audience: Advanced stage biotechnology students, PhD students, The national DIA-NET Doctoral Programme

Description: The theme of this year's course is "Diagnostic technologies  -  reporters, platforms, and reagents". For the course presenters from both academia and industry have been invited. The emphasis is on timely topics and trends within the field of in vitro diagnostics, aiming to bring the traditional diagnostics closer to the end-user, both physically and time-wise. This is largely done by the search for novel technologies that can be built into simple, inexpensive test platforms, yet providing a performance that equals that of the centralized test units. In addition to new reporter technologies, test principles and readiness for inexpensive compact instrumental solutions, this development will be critically dependent on new materials and liquid handling. Still one critical aspect is the availability of specifically tailored reagents of superior performance both for traditional proven markers as well as for novel analytes of interest. In the future the markers for ear
ly detection and health risk evaluation will enable the progress within preventive medicine.

http://www.sci.utu.fi/biokemia/opiskelu/tutkijakoulut/Courses_and_events.html

Credits: Mandatory presence (1 credit) and/or participation in the examination (total of 2 credits)


Best regards,
Johanna Vuojola

-----------------------------------------------------

Viestit välitti
Milla Kumin
Tiedotusvastaava, TYK ry